Particle.news

Download on the App Store

Anne Wojcicki’s Nonprofit Secures $305 Million Bid for 23andMe Ahead of Court Approval

A June 17 hearing will decide court approval after several states filed lawsuits challenging the transfer of sensitive genetic data

23andme co-founder Anne Wojcicki
Image
A 23andMe booth at a genealogical event. The Canadian and British commissioners found the company did not have adequate safeguards to protect against cyber threats in 2023, but made adequate improvements to its security by the end of 2024.
Image

Overview

  • The TTAM Research Institute’s $305 million offer outstripped Regeneron’s $256 million bid and covers 23andMe’s genetic testing and telehealth operations
  • The sale hinges on approval by the U.S. Bankruptcy Court for the Eastern District of Missouri, with a decision expected following the June 17 hearing
  • More than two dozen states have lodged objections or lawsuits to block the transfer of consumer genome data over privacy and security concerns
  • Roughly 1.9 million customers—about 15% of the user base—have requested deletion of their data since the March bankruptcy filing after a 2023 breach exposed 7 million accounts
  • TTAM has committed to uphold existing privacy policies, comply with data protection laws and establish a consumer privacy advisory board